Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects
Sponsor: University Hospital, Gentofte, Copenhagen
Summary
This study is an investigator-initiated, randomised, double-blind, placebo-controlled, cross-over human trial investigating the effect of DHA-NAT (C22:6 N-acyl taurine, an endogenous metabolite derived from the omega-3 fatty acid, docosahexaenoic acid) on postprandial plasma triglyceride levels following a high-fat meal.
Official title: Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects (FEAST): a Randomised, Double-blind, Placebocontrolled, Crossover Study
Key Details
Gender
MALE
Age Range
18 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2023-01-01
Completion Date
2025-04-01
Last Updated
2025-03-30
Healthy Volunteers
Yes
Conditions
Interventions
DHA-NAT
Endogenous metabolite of omega-3 fatty acid docosahexaenoic acid
Placebo
Vehicle control (H2O) for the intervention used in the experimental arm (DHA-NAT).
Locations (1)
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Hellerup, Denmark